We would love to hear your thoughts about our site and services, please take our survey here.
Https://view.news.eu.nasdaq.com/view?id=bd8b6954aad29239377b5e90a588c9298&lang=sv&src=micro
Https://view.news.eu.nasdaq.com/view?id=b4306375b6781c0ac169cad7a03f1b897&lang=en&src=micro
Hi John
I dont think CRV are so invold into this RTO
CRV wrote:
the prior approval application submitted to Nasdaq Stockholm, by Hemcheck, has not been approved by Nasdaq
A more correct announcment would be :
the prior approval application submitted to Nasdaq Stockholm, by Hemcheck, has not " jet " been approved by Nasdaq ;)
It is a huge differen between those two text.........:)
Hi John
Well ?
I speak and understand Swedish ;)
Regarding Bio Vitos
They has Not been rejected, they are still waiting to be approved which is common in an RTO's at Nasdaq Stockholm as Nasdaq Stockholm does Not like RTO listings
https://view.news.eu.nasdaq.com/view?id=bde3bf8134360e98527b4a25bbefb5315&lang=sv&src=micro
See Google translation under:
HEMCHECK
Hemcheck extends the subscription period in the deal with Bio Vitos and sets the preliminary issue date to August 28 (Cision)
2023-07-11 11:30
The board of Hemcheck has, in accordance with the terms of the Annual General Meeting's decision, decided to extend the subscription period in the deal with Bio Vitos until 31 August 2023, i.e. the time when new shares can be issued to Bio Vitos. At the same time, a preliminary issue date is set for August 28, when the new shares are supposed to be booked. The record date for the distribution of Hemcheck Holding AB will occur a few days before this, tentatively August 25.
The process with Nasdaq continues and should a final decision from Nasdaq come later, the board reserves the right to change the preliminary dates above.
For further information, contact:
Hemcheck Sweden AB (publ)
Joen Averstad, acting CEO
https://view.news.eu.nasdaq.com/view?id=beb64e06a86548dd2f92c16c791f81787&lang=sv&src=micro
https://www.nasdaqomxnordic.com/aktier/microsite?Instrument=SSE135098
https://www.stormvik.com/tvzinos.php
https://www.stormvik.com/onebas.php
https://www.londonstockexchange.com/news-article/CRV/portfolio-update/15861973
https://www.nasdaqomxnordic.com/aktier/microsite?Instrument=SSE135098
https://www.londonstockexchange.com/news-article/CRV/interim-results/15853692
The investee companies have each demonstrated positive progress during the period however remain at a 'pre-revenue' stage of business development. As previously disclosed on 15 November 2022, the onebas.com domain was transferred out of Garimon during the period into a new entity (Stormfjord Ltd). Stormfjord Ltd subsequently raised $520,000 of arms-length financing, which valued the domain at $5,000,000. The proceeds of the financing were used to upgrade the functionality and capacity of the websites as well as launch a PR / advertising campaign across key target markets.
After the end of the period, BioVitos Ltd reported that it had entered into a conditional agreement (the "Agreement") to undertake a reverse takeover of Hemcheck Sweden AB, a company listed on the Nasdaq Stockholm (as announced on 8 February 2023). As part of the Agreement and subject to approval by Hemcheck's shareholders at an EGM to be convened at a date still to be confirmed, Hemcheck will create a new subsidiary ("NewCo") and transfer all current business and assets of Hemcheck to this new subsidiary. Under the terms of the Agreement, Bio Vitos has agreed to provide Hemcheck with SEK1.23 million in cash, within 14 days after the approval of the transaction by Hemcheck's shareholders.
Bio Vitos will then pay a further SEK4 million in cash, to Hemcheck, within thirty days following the distribution of shares in NewCo to Hemcheck shareholders.
In addition Bio Vitos has agreed to provide Hemcheck with its IP rights (patents or patent applications) in respect of an active substance Iron Succinate (Succifer and used in a marketed product Inofer). In exchange, Bio Vitos will receive 259,654,000 shares in Hemcheck, amounting to circa 88.3% of Hemcheck's share capital.
Desmond Holdings Ltd
Investment Manager to Craven House Capital Plc
https://www.placera.se/placera/pressmeddelanden/2023/02/14/hemcheck-bok****skommunik-for-hemcheck-sweden-ab.html
Google translated from SWE to ENG:
We have already been clear before the summer that a structural deal was a goal and since we did not manage to raise the capital required to take the company to the next level, the cost reductions have been a consequence of this. Although in principle all costs have been reduced, the income does not exceed the costs and the goal is to be able to achieve a structural deal so that all the work we have put in is taken forward in a good way. If this is not successful, the company risks running out of money and having to be delisted in order to further reduce costs. By signing the conditional agreement with Bio Vitos Medical Limited at the beginning of February, we have taken a first step in securing financing for the business. If the deal goes through, it means that the shareholders get a share in the new company and at the same time retain ownership in Hemcheck's current operations. We are also continuing the work to achieve a possible structural deal regarding current operations.
https://hemcheck.se/pressmeddelanden/bok****skommunike-for-hemcheck-sweden-ab-2/
https://hemcheck.se/pressmeddelanden/bok****skommunike-for-hemcheck-sweden-ab-2/
Google translated from SWE to ENG:
We have already been clear before the summer that a structural deal was a goal and since we did not manage to raise the capital required to take the company to the next level, the cost reductions have been a consequence of this. Although in principle all costs have been reduced, the income does not exceed the costs and the goal is to be able to achieve a structural deal so that all the work we have put in is taken forward in a good way. If this is not successful, the company risks running out of money and having to be delisted in order to further reduce costs. By signing the conditional agreement with Bio Vitos Medical Limited at the beginning of February, we have taken a first step in securing financing for the business. If the deal goes through, it means that the shareholders get a share in the new company and at the same time retain ownership in Hemcheck's current operations. We are also continuing the work to achieve a possible structural deal regarding current operations.
https://www.londonstockexchange.com/news-article/CRV/investee-company-update-bio-vitos/15828378
https://mb.cision.com/Main/16884/3710632/1832822.pdf
John
I am from Narvik !
My family was very involved in the resistance, my grandfather was the head of the partisans in Narvik. With respect to his job, he got the German dolk that the German commander gave away as a symbol that the war was ended. That dolk I got it from my mother and now my son is the owner of it. Regarding the movie, really bad, and the part from the bridge was the only part that was filmed locally
From today's landing page on Norway's biggest tabloid VG.no
https://www.tek.no/nyheter/guide/i/y63ddJ/se-forskjellen-paa-stroemmetjenestene?utm_source=vgfront&utm_content=hovedlopet_row37_pos2&utm_medium=dre-63d3e9e136963ba0d07a8cab
Google translated Norwegian text under:
Norwegian Onebas is so different from the other streaming services that it may not belong in the list of services you can subscribe to.
First and foremost because Onebas is not a paid service, nor does it have its own music catalog. How is that actually possible?
Well, to Tek.no, Onebas describes itself as a search service for music more than a music streaming service. The music is not stored with Onebas, as it is with Spotify and the other players.
Instead, Onebas finds the music you're looking for from other open services, such as YouTube and 44 other databases, and conveys it to you through a neater and more unified interface.
The service will ensure the operation and income of the artists you listen to by giving you the opportunity to buy the albums you like best digitally for one dollar each. The distribution shall be 30/70 in favor of the artists.
It is very reasonable, but you have no guarantee of the resolution of the music. It depends on what is out there on other open sources.
Onebas also has no app for mobile or computer, and only works via the browser. If you move away from the website on your mobile, the music stops, so this is primarily a service for desktop users with no need for HiFi streaming or music "on the go".
Try Onebas »